Share research

Next (Trading Update): small profit upgrade
06 Jan, 2026 00:00
Nexts strong Christmas performance has led to yet another profit upgrade as online channel drives growth.
Novo Nordisk (Announcement): oral Wegovy pill gains FDA approval
23 Dec, 2025 00:00
Novo Nordisks oral version of Wegovy has received FDA approval and is expected to launch in early 2026.
Carnival (FY Results): strong momentum continues
19 Dec, 2025 00:00
Carnival has posted record profit for 2025 and expects further progress in the New Year.
BP (Announcement): CEO resignation and succession
18 Dec, 2025 00:00
Murray Auchincloss has stepped down as CEO with immediate effect. Woodside Energys Meg ONeill is set to take the reins next year.
Coca-Cola (Announcement): CEO succession confirmed
11 Dec, 2025 00:00
Coca-Colas CEO is stepping down in the new year, and current COO Henrique Braun is set to succeed him.
TUI (FY Results): record profits, dividend payments return
10 Dec, 2025 00:00
TUI delivered record profits in 2025, giving management the confidence to announce the return of dividend payments.
Ashtead (Q2 Results): as expected
09 Dec, 2025 00:00
Ashtead didnt throw too many surprises, but the new buyback for 2026 shows confidence in cash flows.
British American Tobacco (FY Update): trading in-line
09 Dec, 2025 00:00
British American Tobaccos year-end update suggests improving momentum, giving management the confidence to announce a �1.3bn buyback for 2026.
Smith & Nephew (Announcement): updated guidance and strategy
08 Dec, 2025 00:00
Smith and Nephew is on track to meet this years guidance. Its also set out a three-year plan alongside some admirable financial targets.
The Magnum Ice Cream Company (Announcement): completes separation from Unilever
08 Dec, 2025 00:00
The Magnum Ice Cream Company completes its spin-off from Unilever and begins trading on stock markets as a standalone business.

Existing client?
Log in to your account »

Important information

Spread Betting and CFD trading carry a high level of risk to your capital; you should ensure you understand the risks involved. Please read the full risk warning.

Have a question?

Call us on 0117 988 9915
8.00am to 6.00pm (Monday to Friday)

HL Markets account holders
Call us on 020 7573 0055
Email us

ShareCast

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

Spread Bets and CFDs are leveraged products. Spread Betting and CFD trading typically require the deposit of a small percentage of the total trade value, profits & losses can quickly exceed your deposits requiring you to make further payments. Ensure that you understand the risks as these products are not suitable for everyone, if you are in doubt seek personal advice. This website does not constitute investment advice.

You can find details of the charges for particular Markets within the relevant Market Information tab, which is located on the Trading Platform next to each Market or by calling IG on 0207 573 0055. Hargreaves Lansdown Asset Management is authorised and regulated by the Financial Conduct Authority, FCA Register number 115248. IG is a trading name of IG Markets Limited and IG Index Limited. CFDs provided by IG Markets Limited, spread betting provided by IG Index Limited. Both IG Markets Limited (register number 195355) and IG Index Limited (register number 114059) are authorised and regulated by the Financial Conduct Authority.

Please ensure you have read the CFD Key Information Document and Spread Betting Key Information Document to better understand the nature, risks and costs of CFD and Spread Betting products, as well as your potential gains and losses when using them before deciding to invest.

Statutory disclosures | What are the risks? | Privacy Policy | Site map | Accessibility